Allosteric Coupling Between Drug Binding and the Aromatic Cassette in the Pore Domain of the hERG1 Channel: Implications for a State-Dependent Blockade

Frontiers in Pharmacology
Meruyert KudaibergenovaHenry J Duff

Abstract

Human-ether-a-go-go-related channel (hERG1) is the pore-forming domain of the delayed rectifier K+ channel in the heart which underlies the IKr current. The channel has been extensively studied due to its propensity to bind chemically diverse group of drugs. The subsequent hERG1 block can lead to a prolongation of the QT interval potentially leading to an abnormal cardiac electrical activity. The recently solved cryo-EM structure featured a striking non-swapped topology of the Voltage-Sensor Domain (VSD) which is packed against the pore-domain as well as a small and hydrophobic intra-cavity space. The small size and hydrophobicity of the cavity was unexpected and challenges the already-established hypothesis of drugs binding to the wide cavity. Recently, we showed that an amphipathic drug, ivabradine, may favorably bind the channel from the lipid-facing surface and we discovered a mutant (M651T) on the lipid facing domain between the VSD and the PD which inhibited the blocking capacity of the drug. Using multi-microseconds Molecular Dynamics (MD) simulations of wild-type and M651T mutant hERG1, we suggested the block of the channel through the lipid mediated pathway, the opening of which is facilitated by the flexible phenylala...Continue Reading

References

Jul 1, 1992·European Heart Journal·M ZimmermannA Bloch
Oct 1, 1995·Circulation Research·H J DuffR S Sheldon
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J W Warmke, B Ganetzky
Feb 1, 1997·Circulation Research·R S WymoreI S Cohen
Feb 29, 2000·The Journal of General Physiology·J S MitchesonM C Sanguinetti
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·J S MitchesonM C Sanguinetti
May 8, 2001·Trends in Pharmacological Sciences·J I VandenbergT J Campbell
Jul 17, 2001·Molecular Pharmacology·K KamiyaM C Sanguinetti
May 9, 2003·American Journal of Physiology. Gastrointestinal and Liver Physiology·A M FarrellyK D Keef
Jul 4, 2003·British Journal of Pharmacology·John S Mitcheson
Mar 20, 1965·Lancet·C ROMANO
Dec 31, 2003·The Journal of Biological Chemistry·David FernandezMichael C Sanguinetti
Jul 22, 2004·Molecular Pharmacology·Matthew PerryJohn Mitcheson
Aug 17, 2004·Molecular Pharmacology·Harry J WitchelJohn S Mitcheson
Mar 3, 2005·The Journal of Chemical Physics·Yibing ShanDavid E Shaw
Jul 1, 2005·American Journal of Physiology. Cell Physiology·Miriam GuizyCarmen Valenzuela
Feb 14, 2006·Molecular Pharmacology·Kaichiro KamiyaMichael C Sanguinetti
Mar 2, 2006·Toxicologic Pathology·Gary A GintantBryan F Cox
Mar 24, 2006·Nature·Michael C Sanguinetti, Martin Tristani-Firouzi
Oct 24, 2006·Biochemical and Biophysical Research Communications·James T MilnesJules C Hancox
Jun 27, 2007·British Journal of Pharmacology·D StorkS Hering
Feb 19, 2008·Journal of Molecular Biology·Sergei Y Noskov, Benoît Roux
Mar 21, 2008·Journal of Computational Chemistry·Sunhwan JoWonpil Im
Jan 28, 2010·ChemMedChem·Anna StaryBert L de Groot
Apr 9, 2010·American Journal of Physiology. Cell Physiology·Sindura B GanapathiKeith S Elmslie
May 26, 2010·The Journal of Physical Chemistry. B·Jeffery B KlaudaRichard W Pastor
Jun 16, 2012·The Journal of Physical Chemistry. B·Jeffery B KlaudaWonpil Im
Sep 20, 2012·Physiological Reviews·Jamie I VandenbergAdam P Hill
Apr 13, 2013·Journal of Computer-aided Molecular Design·G Madhavi SastryWoody Sherman
Nov 5, 2013·The Journal of Chemical Physics·Ross A LippertDavid E Shaw
Apr 26, 2015·Journal of the American Heart Association·Dario MelgariJules C Hancox
Jul 15, 2015·Journal of Molecular and Cellular Cardiology·Dario MelgariJules C Hancox
Oct 31, 2015·Pharmacology Research & Perspectives·Roberta GualdaniGiovanni Lentini
Apr 14, 2016·Scientific Reports·P SaxenaA Stary-Weinzinger
Aug 5, 2016·Biochemistry·Brian J BenderRocco Moretti
Oct 13, 2016·Scientific Reports·Yibo WangSergei Yu Noskov
Nov 8, 2016·Nature Methods·Jing HuangAlexander D MacKerell
Apr 22, 2017·Cell·Weiwei Wang, Roderick MacKinnon
Jan 13, 2018·Scientific Reports·Logan C MacdonaldDavid Fedida

❮ Previous
Next ❯

Citations

Jun 2, 2021·Journal of Molecular and Cellular Cardiology·Kevin R DeMarcoIgor Vorobyov
Aug 24, 2021·Journal of Chemical Information and Modeling·Kuo Hao LeeLei Shi
Sep 11, 2021·Journal of Chemical Information and Modeling·Teresa Maria CreanzaGiuseppe Felice Mangiatordi

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

Protein Preparation Wizard
ROSETTA
Anton
Schrödinger
GUI
GLIDE
Shaw
Ligprep
NBFIX
Ligprep Wizard

Related Concepts

Related Feeds

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.